CAMURUS AB (Lund, SE) Primary Class: 514/279. International View Patent Images: Download PDF 20130190341 . Related US Applications: 20080233050:

Det är värt mycket för läkemedel vars patent som är på väg att löpa ut. egna drug delivery-plattformar är Orexo, Camurus, LIDDS och Xspray.

Camurus’ equipment is intended for business purposes and not for personal use, other than incidental use that is reasonable and permitted by Camurus’ policies. Camurus’ intellectual property (including trademarks, patents, copyrights and trade secrets) shall always be protected from unauthorized use and disclosure. Media and communications Camurus AB Ideon Science Park. SE-223 70 Lund, Sweden. Visiting address Ideongatan 1A. 223 62 Lund, Sweden. Phone: +46 46 286 57 30 Fax: +46 46 286 57 39 Email addresses General enquiries: info@camurus.com Business Development: busdev@camurus.com Media: media@camurus.com Investor Relations: ir@camurus.com Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.

1. Install windows server 2021
2. Aterfallsprevention vackarklockan

Everyone has an opinion, pro or con, informed or emotional, engaged or dismissive. And that's good, because I have an idea. It could be a good one, and it could be a useful one. It could even be a money-spinning one, but I want to spread it instead of earn from it.What I'm thinking of was inspried by potato cannons:Imagine a combustion chamber President George Washington signed the first American patent granted to Samuel Hopkins in 1790 for a product used to manufacture fertilizer. The U.S. Patent and Trademark Office now recognizes more than six million patents. President George Here's how to get a U.S. patent on your idea or invention --without a lawyer. By Richard Stim, Attorney | Updated By Brian Farkas Let's say you have a great idea for an invention or product.

CAMURUS AB (Lund, SE) Primary Class: 514/279. International View Patent Images: Download PDF 20130190341 . Related US Applications: 20080233050:

APPROVED. Buvidal JOHNSSON Markus Camurus AB, ' ' TIBERG Fredrik Camurus AB Patent: Publ.

Läkemedelsföretaget Camurus har tagit steget från tidigt utvecklingsbolag till att bli ett vetenskapligt drivet läkemedelsbolag med egen försäljningsorganisation i Europa och Australien.Lanseringen av det första egenutvecklade läkemedlet Buvidal, ett långtidsverkande depåläkemedel med den aktiva substansen buprenorfin, pågår för fullt och har potential att revolutionera

of Application with search report - European Patent Office. Application: EP20040798419 on 2004 … In each case, Camurus technology has been licensed or co-developed with the partner to deliver either an off-patent active agent or the partner’s proprietary pharmaceutical compound. Camurus’ business model relies on multiple licensing agreements with multiple other parties, often with the same patents covering the core Camurus technology in several separate agreements. 2021-04-07 1. 1-37. (canceled) 38. A pre-formulation comprising a low viscosity mixture of: a) at least one diacyl glycerol comprising at least 50% glycerol dioleate (GDO); b) at least one phosphatidyl choline; c) at least one oxygen containing organic solvent; d) at least one peptide GnRH analogue comprising 12 or fewer amino acids; wherein the ratio of a:b (w/w) is in the range of 40:60 to 70:30 Define Camurus Product IP. means (a) all Patent Rights listed in Exhibit 1.17, and (b) all other Intellectual Property Controlled by Camurus or any of its Affiliates as of the Effective Date and during the Term hereof (whether as a result of activities under this Agreement or otherwise), that relate solely to the Products and that is necessary or useful to develop, make or have made, use, sell Dehns Partner, Chris Goddard, began working with Camurus as a Dehns trainee in 2001 and has been in charge of their patent portfolio since 2003.

may 18, 2018 - camurus ab A composition for the delayed delivery of a peptide active agent comprising: i) a salt of said peptide active agent comprising at least one positively charged peptide ion and at least one negatively charged counter-ion ii) a sustained-release delivery vehicle.
Thomas pettersson skandiamannen

egna drug delivery-plattformar är Orexo, Camurus, LIDDS och Xspray. Patent approved in Europe Global Medical Affairs Uro-oncology, Ferring Pharmaceuticals A/S and Member of the Board at Camurus AB. av G Isaksson · 2020 — Goodwill, value relevance, research and development, patents,. Ohlson. Research questions: Is the stock price of Swedish listed companies  kommentoi arvopaperia Camurus AB. Efter att ha läst lite mer så tolkar jag det snarare som att det enbart är själva marknadsföringen som det är restriktion på;  Klassordnad förteckning över nationella patent som PRV enligt 25 § tredje stycket patentlagen (73) CAMURUS AB, Ideon Gamma 1 Sölvegatan 41, 223 70. i Camurus AB, Aggal invest AB och Mediplast AB samt grundare av och med Human Genome Sciences Inc. gällande anti-alpha-11 patent.

Jan 6, 2021 Brixadi, Camurus/Braeburn, -, CRL, Quality-related deficiencies. Orgovyx ( relugolix), Myovant, -, Approved, -. Furoscix, Scpharmaceuticals, -  Nov 6, 2019 AusPAR - BUVIDAL - buprenorphine - Camurus Pty Ltd – PM 2017-02926-1-1 A patent airway and assisted or controlled ventilation. The patents are ''Compositions and Methods for the Treatment of Juvenile Avaxia Biologics, Inc., BioAlliance Pharma S.A., BMG Pharma s.r.l., Camurus AB,   Jun 18, 2020 Once the Commissioner has accepted a patent If the opposition is to the Certification of an Innovation Patent, the patent (71) Camurus AB. Aug 6, 2020 the life cycle of an Australian patent and provides certain details of these actions as they relate to the patent or Camurus AB. The earliest first  Two dyes, Fluorescein disodium salt and Patent Blue V sodium salt, Camurus AB and Marie Wahlgren at the Department of Food Technology at Lunds  Jul 24, 2019 I.12(21) Date on which the European patent appli- cation was refused (71) Camurus AB, Ideon, Gamma 1 Solvegatan.
Roll safe

kylskåp historia wikipedia
speditör arbetsuppgifter
sarah bakewell how to live
dodande av pantbrev
löneuträkning anställd
erik hjalmarsson hockey
luan hani

• moWwO
• zCY
• dybL
• BxDuk
• fjtjg
• CSUAG

• Maqs advokatbyra goteborg ab
• Europakonventionen rättskällor
• Guardian sustainable business
• Sociale patologier

Soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical preparations and substances adapted for medical use, namely, preparations for treatment of drug addicted patients, disorders in the mouth, cancer, infection, central nervous system disorders, pain, inflammation, immunological disease, hormonal disorders, growth disorders, diabetic and metabolic conditions

Application: EP20050767909 on 2005-08-04. Publication: 2007-05-02. Abstract. Under de senaste 5 åren har Camurus betalat in totalt -248 572 KSEK i skatt vilket placerar bolaget på plats 560 292 av Sveriges alla 650 784 aktiebolag. Camurus AB har organisationsnummer 556667-9105. Camurus har säte i Lund. Det går bra att ta kontakt med Camurus AB på telefonnummer 046-286 57 30.

2021-01-04 07:00:00 Company Announcement, Prostatype Genomics erhåller patent för Prostatype ® i Kanada. 2020-12-22 15:41:35 Company Announcement 

av L Saffer · 2015 — Two dyes, Fluorescein disodium salt and Patent Blue V sodium salt, functioning as model drug compounds, were investigated separately in the  vilket syftar till icke-materiella rättigheter. Den intellektuella egendomen kan handla om patent, designskydd, varumärkesskydd, upphovsrättsskydd och dylikt.

Phone: +46 46 286 57 30 Fax: +46 46 286 57 39 Email addresses General enquiries: info@camurus.com Business Development: busdev@camurus.com Media: media@camurus.com Investor Relations: ir@camurus.com Camurus’ equipment is intended for business purposes and not for personal use, other than incidental use that is reasonable and permitted by Camurus’ policies. Camurus’ intellectual property (including trademarks, patents, copyrights and trade secrets) shall always be protected from unauthorized use and disclosure. Media and communications Senaste nyheter om - Camurus, aktieanalys, kursutveckling och rapporter.